Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Paratek Pharmaceuticals, Inc. (PRTK) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $4.60 Metrics
OS: 57.3 M
Market cap: $264 M
Net debt: $216 M
EV: $479 M

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
Revenues160.3130.246.916.517.1110.40.073.6
            Revenue growth23.1%177.4%183.6%-3.3%-84.5%380575.9%-100.0%1595.4%
Cost of goods sold23.121.58.73.5121.297.2109.570.1
Gross profit137.2108.638.313.1-104.113.2-109.53.6
            Gross margin85.6%83.5%81.6%78.9%-608.1%12.0%-377537.9%4.8%
Selling, general and administrative145.6119.489.989.163.7   
Research and development37.830.423.939.657.560.183.550.8
General and administrative     37.026.420.0
EBITA-46.2-41.1-75.5-115.6-104.0-84.4-109.5-70.2
            EBITA margin-28.8%-31.6%-160.9%-698.9%-607.9%-76.5%-377693.1%-95.3%
Amortization of intangibles      0.30.6
EBIT-46.2-41.1-75.5-115.6-104.0-84.4-109.8-70.8
            EBIT margin-28.8%-31.6%-160.9%-698.9%-607.9%-76.5%-378727.6%-96.1%
Pre-tax income-63.5-58.5-96.5-128.5-111.9-88.3-111.6-70.9
Income taxes0.10.60.00.30.50.80.00.0
            Tax rate  0.0%   0.0%0.0%
Net income-63.6-59.1-96.5-128.8-112.4-89.1-111.6-70.9
            Net margin-39.7%-45.4%-205.7%-778.5%-656.4%-80.7%-384951.7%-96.3%
 
Diluted EPS($1.17)($1.22)($2.19)($3.93)($3.57)($3.32)($5.51)($4.29)
Shares outstanding (diluted)54.448.444.232.831.526.820.316.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy